We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO.

Website: http://www.ipsen.com

Employees: 6033

HQ: +33 1 58 33 50 00

Location: Boulogne-Billancourt, Ile-de-France, FR

Revenue: $3.2 billion

Ipsen Biopharmaceuticals is a global biotech company that focuses on innovative solutions for various healthcare needs. With a strong presence in over 100 countries, Ipsen is committed to providing quality products and services to improve the lives of patients and healthcare professionals. If you're looking for contact information for Ipsen Biopharmaceuticals, you've come to the right place. At ConnectPlex, we provide accurate and up-to-date contact information for companies like Ipsen, making it easier for you to connect with the right people and grow your business. Our database includes contact information for key decision-makers and professionals in various departments at Ipsen Biopharmaceuticals. Whether you're looking to collaborate on a new project, inquire about their products, or explore business opportunities, we've got you covered. Our lead generation products are designed to help you connect with the right people at the right time, and our SEO-focused approach ensures that our content ranks high in search engines. So why wait? Start your search for Ipsen Biopharmaceuticals contact information today and take the first step towards building a successful business relationship.

Ipsen Biopharmaceuticals is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. With a commitment to oncology, neuroscience, and rare disease, Ipsen develops and commercializes innovative medicines that aim to improve the lives of patients worldwide. Located in Basking Ridge, New Jersey, Ipsen has a strong presence in over 30 countries and commercializes more than 20 drugs in over 115 countries. The company's R&D efforts are focused on its innovative and differentiated technological platforms, located in leading biotechnological and life sciences hubs such as Paris-Saclay, France; Oxford, UK; and Cambridge, US. Ipsen's dedication to oncology is evident in its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma, and pancreatic cancer. The company's neuroscience division is advancing at an unprecedented rate, with a focus on developing treatments for conditions such as Parkinson's disease, Huntington's disease, and multiple sclerosis. In addition to its work in oncology and neuroscience, Ipsen also has a well-established Consumer Healthcare business. With a strong commitment to innovation and patient care, Ipsen's total sales reached nearly 2.5 billion euros in 2020. Ipsen's management team includes experienced executives such as David Meek, Chief Executive Officer, and Saurabh Sewak, Chief of Staff to the CEO and Head of Strategy. The company's employees worldwide are dedicated to its mission of improving the lives of patients and their families. Overall, Ipsen Biopharmaceuticals is a leading player in the biopharmaceutical industry, with a strong focus on innovation, patient care, and employee dedication. Its commitment to developing and commercializing innovative medicines has made it a trusted name in the healthcare industry.

Ipsen is a global company that creates and sells specialized medicines for people with serious illnesses. They focus on three main areas: cancer, brain disorders, and rare diseases. They have a strong commitment to cancer treatment and offer several therapies for different types of cancer. They are also leaders in neuroscience and have a well-established consumer healthcare business. In 2020, they made almost €2.5 billion in sales and have a presence in over 115 countries. They have a large research and development team that works on new and innovative technologies in leading biotechnology hubs around the world. They have about 5,700 employees.